Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Barhemsys

FDA, Industry, Regulations, Vaccines

FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of PONV

February 27, 2020

Via: Drugs.com

Acacia Pharma Group plc (“Acacia Pharma” or the “Company”), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures, or cancer […]